Denial driver
Modifier 25 unsupported
Why it hits Boston hardest
Same-day E&M plus procedure on most visits
247MBS safeguard
Note review proves a separately identifiable service
Dermatology billing · Boston, MA
Dermatology medical billing services in Boston from 247MBS fit a market defined by heavyweight academic dermatology at Mass General Brigham, Beth Israel Deaconess, Tufts, and Boston University, a rich commercial payer book, and MassHealth's ACO-based Medicaid.
Since 2005 you get a dedicated account manager, a free 360° dashboard, HIPAA plus SOC 2 Type II protection, and coders who understand Massachusetts payers and the referral dynamics of a teaching-hospital city.
Boston's most common revenue leak is not a low fee schedule — it is the modifier 25 edit and the pathology-component split going wrong in a market where nearly every encounter carries both an evaluation and a procedure. With so much specimen work routed through teaching-hospital labs, the professional-versus-technical line gets blurred, and same-day E&M claims get bundled away when the note does not clearly stand on its own. The table below is where we concentrate first, because in a high-commercial Boston book these are the denials that quietly compound.
Modifier 25 unsupported
Same-day E&M plus procedure on most visits
Note review proves a separately identifiable service
Path 26 / TC component error
Specimens split across teaching-hospital labs
Correct professional/technical split per specimen
Malignant coded before pathology
High academic surgical throughput
Final-code held until the path report confirms
MassHealth ACO referral/auth gap
ACO plan controls referrals and authorization
Eligibility and auth confirmed with the assigned ACO
Size / site / margin not documented
Excision coded without the pre-cut measurement
Diameter and margins captured before the specimen ships
AK destruction frequency / LCD
Medical-necessity limits on lesion counts
Counts validated against the active coverage policy
Biologic prior auth missing
Buy-and-bill without commercial pre-auth
Authorization secured and units reconciled first
CPT, HCPCS, J-codes, and modifiers appear only in the table so the prose stays plain.
| Service | Codes | What we confirm before it goes out | Boston payer note |
|---|---|---|---|
| E&M with a same-day procedure | 99202–99215 + modifier 25 | Separately identifiable, documented evaluation | Commercial edits scrutinize mod 25 |
| Skin biopsy | 11102–11107 | Method plus per-additional-lesion add-ons | Frequency review on repeat sites |
| Excision — benign / malignant | 11400–11446 / 11600–11646 | Site, pre-excision diameter, margins; pathology before malignant final-code | Heavy academic referral volume |
| Destruction — AK / benign / malignant | 17000 / 17003 / 17004, 17110–17111, 17260–17286 | AK counts and frequency vs the LCD | Medical-necessity documentation |
| Mohs micrographic surgery | 17311–17315 | Stages and blocks; no separate path same specimen; modifier 58 on staged closure | Prior auth on higher-cost cases |
| Dermatopathology | 88304 / 88305, 88312–88314 | Modifier 26 / TC split, in-house vs send-out | Sets technical-component billing |
| Biologics (buy-and-bill) | J-codes + 11900 / 11901 | Prior authorization, unit math, JW waste | Medical vs specialty-pharmacy benefit |
| Cosmetic (self-pay) | 64612 / J0585, fillers | ABN plus GA/GX/GY/GZ; collected before service | Never routed to MassHealth as covered |
Boston is one of the most academic medical markets in the country, and its dermatology billing reflects that. Mass General Brigham, Beth Israel Deaconess, Tufts Medical Center, and Boston University all run dermatology programs, and the community practices that surround them operate inside a referral web where specimens, second opinions, and complex surgical cases move between sites. That means a Boston practice bills a lot of dermatopathology and a lot of specimen-driven excision, and the professional-versus-technical component has to be assigned correctly every time or revenue slips between the reading and treating physicians.
The payer side is a two-speed system. Massachusetts carries one of the deepest commercial books in the nation — Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, and Tufts Health Plan — which pays well but edits hard on modifier 25 and medical necessity. Underneath it runs MassHealth, the state Medicaid program, restructured around Accountable Care Organizations that control referrals and authorization through an assigned ACO. Covered medical and surgical dermatology has to be verified against the patient's specific ACO before the visit, and cosmetic services kept entirely on the cash ledger. A generalist billing company that treats MassHealth as a single plan will miss the ACO routing and lose otherwise-clean claims.
The demographic underneath is a large, insured, aging-in-place population with steady skin-cancer surgical volume plus a younger professional base that mixes medical and cosmetic care. That blend keeps the covered-versus-cash discipline central: the ABN, the up-front cosmetic collection, and the clean separation of aesthetic work from medically necessary treatment are everyday tasks, not exceptions.
Revenue review
A certified dermatology billing specialist reviews your coding, unit counts, authorizations and aged A/R against the payers you actually bill in Boston, MA — and puts a number on what your current process is leaving on the table.
A dermatology specialist will reach out within one business day.
A dermatology specialist will reach out within one business day.
Practices here lose money less to rates than to unsupported modifier 25 claims, misassigned pathology components, and ACO authorization gaps no one has time to chase. When you outsource dermatology billing in Boston to a specialty medical billing services company, the same-day E&M is documented to survive the edit, the pathology split is assigned per specimen, MassHealth ACO eligibility is confirmed before the encounter, and every denial is worked rather than written off. Our AAPC-credentialed coders handle Mohs, destruction, and dermatopathology as daily work, not an occasional exception.
We hold ourselves to a 99% first-pass clean-claim rate, up to 40% fewer denials, 90% of worked denials recovered, days in A/R under 25, and 98% client retention, all visible on your free 360° dashboard with a dedicated account manager owning the book. See our dermatology billing services overview and our Massachusetts medical billing page for the full scope, and we manage the prior authorization load that commercial biologics and higher-cost surgery demand. A professional dermatology billing company built for this specialty simply keeps more of what you earn.
We provide medical billing for dermatologists throughout Greater Boston — solo and independent practices, group medical dermatology, surgical dermatology and Mohs micrographic surgeons, dermatopathology labs, and hybrid cosmetic-plus-medical offices from Back Bay, Beacon Hill, and the Longwood Medical Area out to Cambridge, Brookline, Newton, and Somerville. Whether you run a teaching-hospital-affiliated surgical practice, a busy medical-derm office, or a growing group adding a provider who needs credentialing, your claims are worked by coders who understand dermatology and this market.
Because so many Boston practices take referral specimens from the academic systems, we pay particular attention to reconciling the professional and technical components so nothing falls between the reading and treating physicians, and we adjust that split whenever a practice brings reads in-house or moves to a send-out arrangement.
Medical billing for dermatology in Boston protects the two claim types this teaching-hospital market puts most at risk: the same-day E&M that carries a procedure and the dermatopathology component split across referral labs. 247MBS documents each modifier 25 evaluation to survive the edits Blue Cross Blue Shield of Massachusetts, Harvard Pilgrim, and Tufts Health Plan apply hardest, assigns the professional-versus-technical pathology split per specimen, and confirms MassHealth ACO eligibility before the visit. Malignant excisions wait for the path report, and cosmetic work stays on the cash ledger. Since 2005 our AAPC-credentialed coders have held a 99% first-pass clean-claim rate and A/R under 25, so a community practice around Mass General Brigham keeps the revenue its schedule actually earns.
Boston practices are billed out of the same Massachusetts desk. Statewide payer detail lives on the Massachusetts page.
Dermatology Billing company — the codes, unit rules and denials nationally, without the local layer.
Yes. We verify eligibility with the patient's assigned Accountable Care Organization, confirm referral and authorization requirements before the visit, and keep cosmetic services off the Medicaid ledger so covered medical and surgical dermatology is paid the first time.
We review the note before submission to confirm the same-day evaluation is genuinely separate and identifiable from the procedure, so the E&M survives the edit that BCBS of Massachusetts, Harvard Pilgrim, and Tufts apply most aggressively.
Yes. We apply the modifier 26 / TC split based on whether slides are read in-house or sent out, keep pathology off the Mohs specimen it is already bundled into, and reconcile the claim streams so neither the reading nor the treating physician double-bills or under-bills.
From solo practices to multi-provider groups, we bill Dermatology for Boston practices with a dedicated account manager, certified coders and a live dashboard — so the units, authorizations and appeals that decide your month stop being the thing nobody has time for.
Prefer email? sales@247medicalbillingservices.com